Brian Piekos
Chief Financial Officer · 5 filings · Latest: Jun 11, 2026
KalVista Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KALV | Brian Piekos | Chief Financial Officer | May 22, 2026 | Sale | $26.78 | 1,489 | $39.9K | 21,661 | |
KALV | Brian Piekos | Chief Financial Officer | May 21, 2026 | Option Exercise | — | 5,000 | — | 23,150 | |
KALV | Brian Piekos | Chief Financial Officer | Apr 17, 2026 | Sale | $20.22 | 1,862 | $37.6K | 18,150 | |
KALV | Brian Piekos | Chief Financial Officer | Apr 16, 2026 | Option Exercise | — | 6,250 | — | 20,012 | |
KALV | Brian Piekos | Chief Financial Officer | Feb 23, 2026 | Sale | $15.57 | 1,767 | $27.5K | 13,762 | |
KALV | Brian Piekos | Chief Financial Officer | Feb 21, 2026 | Option Exercise | — | 5,000 | — | 15,529 |